Process for preparing and purifying...

Details Process for preparing and purifying... Process for preparing and purifying...

2003-01-16

2004-08-03

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

06770762

ABSTRACT:

FIELD OF THE INVENTION
The invention relates to a process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole which can be used on an industrial scale.
BACKGROUND OF THE INVENTION
The preparation of 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole by reacting 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid with N-methyl-o-phenylene-diamine dihydrochloride is known from J. Med. Chem. (1993), 36(25), 4040-51 and International Patent Application WO 0063158.
1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole is of major importance as an intermediate product in the industrial synthesis of pharmaceutically active substances, particularly the pharmaceutically active substance telmisartan (Drugs of the future 1997, 22(10), 1112-1116). This gives rise to the need for a high level of purity. The purification process using ethyl acetate and diethyl ether known from the abovementioned literature is unsuitable as a large-scale process as diethyl ether, for example, presents a safety problem and requires careful handling on account of its toxicity, its tendency to form peroxides and the risk of explosion of its vapours, e.g. by electrostatic discharge.
The aim of the present invention is therefore to provide a process which can be used on an industrial scale for purifying the 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole prepared by the abovementioned methods of synthesis and the variants thereof described in this specification.
DETAILED DESCRIPTION OF THE INVENTION
Surprisingly it has been found that 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole may be obtained in a highly pure form by a process suitable for use on an industrial scale if the essential purification steps are carried out using charcoal.
The invention therefore relates to a process which can be used on an industrial scale for purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole which has been prepared by reacting 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid or the salts thereof with N-methyl-o-phenylene-diamine or the salts thereof, in which the crude product is treated with charcoal.
In a preferred process according to the invention 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid is reacted with N-methyl-o-phenylene-diamine or the salts thereof, preferably in the form of a salt, preferably in the form of the phosphate, chloride or bromide salt, more preferably in the form of the phosphate or chloride salt, most preferably in the form of the phosphate salt, in the presence of methanesulphonic acid and phosphorus pentoxide.
Also preferred is a process wherein the reaction is carried out at a temperature of 125 to 145° C.
In a particularly preferred process, the charcoal treatment purification step is carried out after the end of the reaction, hydrolysis and pH adjustment, by adding the reaction mixture to the charcoal.
Also particularly preferred is a process wherein the charcoal treatment purification step is carried out at a temperature of 70 to 80° C.
Of particular importance is a process wherein the charcoal treatment purification step takes place at a pH of 0.7 to 1.2.
Also of particular importance is a process wherein the amount of charcoal used in a purification step is from 5 to 20 percent by weight of the 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid used.
In a particularly preferred process, the purification step is repeated one to three times after the filtration or centrifugation of the reaction mixture.
In another particularly preferred process, after the purification by treatment with charcoal, the following steps take place in succession:
a) an organic solvent is added,
b) a base is added to obtain a pH of 5 to 6,
c) the aqueous phase is separated off,
d) the 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole is separated from the organic phase by crystallization and subsequent filtration or centrifugation.
In another preferred process, isopropanol is used as the organic solvent in step a).
Also particularly preferred is a process wherein, in step b), the base is added at a temperature of 70 to 80° C.
Also particularly preferred is a process wherein, in step d), the crystallization is carried out by the addition of water.
1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole is used in particular for preparing telmisartan. Telmisartan may be prepared using the method described in Drugs of the future 1997, 22(10), 1112-1116 according to the following synthesis diagram I:
The following variants A, B, C, D and E are particularly preferred embodiments of the process according to the invention.
Variant A:
2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid (PMBC) and N-methyl-o-phenylenediamine (NMPD) or the salts thereof are added successively to a solution of an organic acid, preferably methanesulphonic acid, phosphorus pentoxide, thionyl chloride, sulphonyl chloride, acetic anhydride or polyphosphoric acid, preferably methanesulphonic acid, phosphorus pentoxide or thionyl chloride and/or mixtures or dilutions thereof with inert organic solvents, preferably N-methylpyrrolidinone, o-, m- or p-xylene, most preferably N-methylpyrrolidinone, with stirring at a temperature of 100 to 160° C., preferably at 115 to 150° C., particularly at 125 to 145° C., most preferably at about 135° C. PMBC and NMPD are used in a molar ratio of 1.0:0.5 to 1.0:2.0, preferably 1.0:0.7 to 1.0:1.5, more preferably 1.0:1.0.
The amount of organic acid and organic solvent is determined according to the amount of PMBC used. Up to 10 mol, preferably 2 to 8 mol, most preferably about 7 mol of organic acid and up to 2 mol, preferably 0.5 to 1.5 mol, most preferably about 1 mol of phosphorus pentoxide are used per mol of PMBC.
After the addition has ended the mixture is stirred for up to 10 hours, preferably 1 to 4 hours, most preferably 3 hours at a temperature of 100 to 160° C., preferably 125 to 145° C., preferably 135° C. Then, in order to hydrolyse the excess acid component (anhydride, acid chloride), water is added to the organic acid used, for example phosphorus pentoxide, at a temperature of not more than 100° C., preferably not more than 90° C., in a ratio of 1.0:2.0 to 1.0:0.1, preferably 1.0:1.4 to 1.0:0.2.
After hydrolysis is complete, the pH is adjusted to 0.2 to 1.8, preferably 0.5 to 1.5, most preferably 0.7 to 1.2, more preferably 0.9 by the addition of a base, preferably sodium hydroxide, sodium carbonate or an amine, most preferably sodium hydroxide, sodium carbonate, ammonia, pyridine or triethylamine, most preferably sodium hydroxide solution or ammonia, more preferably sodium hydroxide. The temperature of the reaction mixture should not exceed 100° C. during this addition and is preferably below 90° C., most preferably from 70-80° C.
While the temperature range remains constant, charcoal, preferably activated charcoal, preferably “dry activated charcoal”, “moist activated charcoal” or “granulated activated charcoal”, more preferably “dry activated charcoal” of the SX 2, SX Ultra or L2S grade is added to the reaction mixture to purify it. The activated charcoal preferably used in the process according to the invention may be obtained for example from the companies Norit, Atofina or Begerow. The amount of charcoal used in each purification step should be from 5 to 20 percent by weight, preferably from 6 to 15 percent by weight, most preferably from 8 to 12 percent by weight, more preferably about 10 percent by weight of the amount of PMBC used. The reaction mixture combined with charcoal is stirred for at least 5 min, preferably 5 to 60 minutes, preferably 8 to 50 minutes, most preferably 10 to 30 minutes at a temperature of max. 90° C., preferably at 50 to 80° C., most preferably at 70 to 75° C. and then filtered or centrifuged, preferably filtered. The purification step may be repeated one to ten times, preferably one to five times, most preferably one to three times, preferably twice, with the reaction mixture which has been filter

Affiliated with

Also associated with

Rating

Process for preparing and purifying... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing and purifying..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing and purifying... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3357298